Accessibility
Conduct comparative analyses across multiple sample formats with Discovery’s unrivaled inventory of patient and time-matched samples.
Quality
Purchase with confidence from our ethically collected and hyper-annotated™ matched biospecimens inventory.
Expertise
Engage with our biospecimens and biomarker specialists regarding sample utilization questions or for biomarker discovery and validation services that can streamline your oncology R&D.
Find The Support Your Project Needs With Discovery’s Extensive Range of High-Quality Matched Sample Sets
Available Matched Sets
FFPE Matched Sets
FFPE
- Full FFPE block
- Samples from X oncology indications
- Pathology report of confirmed diagnoses
- Patient and sample data including age, race, gender, resection date, tumor percentage, etc.
Plasma (Streck)
- Plasma collected in Streck cfDNA tubes
- Pathology report and clinical information
Buffy Coat
- Pathology report and clinical information
FFPE
- Full FFPE block
- Samples from X oncology indications
- Pathology report of confirmed diagnoses
- Patient and sample data including age, race, gender, resection date, tumor percentage, etc.
Plasma (K2EDTA)
- Plasma collected in K2EDTA tubes
- Pathology report and clinical information
Buffy Coat
- Pathology report and clinical information
FFPE
- Full FFPE block
- Samples from X oncology indications
- Pathology report of confirmed diagnoses
- Patient and sample data including age, race, gender, resection date, tumor percentage, etc
DTCs
- Cell population analysis and HLA-A02 typing by flow cytometry
- Pathology report and clinical information
- Mutation/biomarker tested patient samples
FFPE
- Full FFPE block
- Samples from 10 oncology indications
- Pathology report of confirmed diagnoses
- Patient and sample data including age, race, gender, resection date, tumor percentage, etc.
Flash Frozen Tissue
- More than 175mg of flash-frozen tissue
SpecimenSeq™ FFPE
- NGS-characterized samples from 15 indications and 273 unique patients
- HAD QGEN MultiModal service with Qiagen Clinical Insights (QCI) report
- Pathology report of confirmed diagnoses
- Patient and sample data including age, race, gender, resection date, tumor percentage, etc.
Plasma
- Pathology report and clinical information
DTCs Matched Sets
DTCs
- Tumor microenvironment analysis and HLA-A02 typing by flow cytometry
- Mutation/biomarker tested patient samples
- PD-L1, MSI, MMR, BRAF, EGFR, KRAS, and NRAS
PBMCs
- Cell counts and viability using AOPI staining
- Pathology report and clinical information
DTCs
- Cell population analysis and HLA-A02 typing by flow cytometry
- Mutation/biomarker tested patient samples
- PD-L1, MSI, MMR, BRAF, EGFR, KRAS, and NRAS
FFPE
- Full FFPE block
- Pathology report of confirmed diagnoses
- Patient and sample data including age, race, gender, resectiond date, tumor percentage, etc.
DTCs
- Cell population analysis and HLA-A02 typing by flow cytometry
- Mutation/biomarker tested patient samples
- PD-L1, MSI, MMR, BRAF, EGFR, KRAS, and NRAS
PBMCs
- Cell counts and viability using AOPI staining
- Pathology report and clinical information
FFPE
- Full FFPE block
- Pathology report of confirmed diagnoses
- Patient and sample data including age, race, gender, resection date, tumor percentage, etc.
BMMC Matched Sets
AML BMMCs
- Cell population analysis and HLA-A02 typing by flow cytometry
- Pathology report with confirmation of diagnosis, donor demographic data, date of procedure, and medical information
- Patient demographic characterization like cell count, viability, age, sex, ethnicity, height/weight, smoking status, alcohol history, etc.
PBMCs
- Cell counts and viability using AOPI staining
- Pathology report and clinical information
MM BMMCs
- Cell population analysis and HLA-A02 typing by flow cytometry
- Pathology report with confirmation of diagnosis, donor demographic data, date of procedure, and medical information
- Patient demographic characterization like cell count, viability, age, sex, ethnicity, height/weight, smoking status, alcohol history, etc.
PBMCs
- Cell counts and viability using AOPI staining
- Pathology report and clinical information
Need biomarker characterization
for your human blood
biospecimens?
While our biospecimens are highly characterized, we also provide streamlined multi-omic biomarker analyses to further characterize biospecimens from our inventory or from your studies via our global CLIA certified service laboratories*.
Genomic Biomarkers
- HudsonAlpha Discovery
- Whole Genome Sequencing
- Whole Exam Sequencing
- Targeting Panels
- Hi-Fi Long Read Sequencing
- RNASeq
- Single Cell Sequencing
Tissue Biomarkers
- IHC
- Multiplexed IF (mIF)
- RNA Scope
- Digital Pathology & Image Analysis
- PCR
- In-Situ Hybridization
- Colorimetric
Cell Services
- Flow Cytometry
- Dissociation & Isolation
- Cell Culture & Expansion
*HudsonAlpha Discovery Sequencing and Bioinformatics laboratory is CLIA registered, pending CAP accreditation.
Learn More
Frequently Asked Questions
How quickly is the plasma processed post blood collection?
Plasma is processed within 2 hours after the blood is collected
For FFPE + Plasma matched sets, when is the blood collected?
For FFPE + Plasma matched sets, blood is collected pre-surgical intervention.
What anticoagulant is used for FFPE + Plasma sets?
EDTA is used for FFPE + Plasma sets.
To propel your projects with The Power of Discovery.™
Contact Us Today
Let us know about your project!
